These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20942098)

  • 21. Surveillance and treatment protocols to detect and treat hepatitis B virus reactivation in hepatitis B surface antigen-negative/antibody to hepatitis B core antigen-positive patients receiving chemotherapy for onco-hematologic malignancies.
    Marignani M; Marzano A
    J Clin Oncol; 2011 Mar; 29(8):e210; author reply e211. PubMed ID: 21220585
    [No Abstract]   [Full Text] [Related]  

  • 22. The serologic markers of hepatitis B virus infection--proper selection and standardized interpretation.
    Caspari G; Gerlich WH
    Clin Lab; 2007; 53(5-6):335-43, 391-400. PubMed ID: 17605409
    [No Abstract]   [Full Text] [Related]  

  • 23. A multiple centre clinical study of third-generation enzyme immunoassays for hepatitis B surface antigen and hepatitis B core IgM class antibody.
    Jakob R
    Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):259-66. PubMed ID: 8318575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of hepatitis B virus markers using a biosensor based on imaging ellipsometry.
    Qi C; Zhu W; Niu Y; Zhang HG; Zhu GY; Meng YH; Chen S; Jin G
    J Viral Hepat; 2009 Nov; 16(11):822-32. PubMed ID: 19486471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoassay and enzyme immunoassay methods for detecting viral hepatitis markers.
    Hanson MR; Polesky HF
    Am J Clin Pathol; 1983 Oct; 80(4 Suppl):590-3. PubMed ID: 6353906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanisms of hepatitis B e antigen seroconversion from the aspect of viral mutation].
    Torii N; Hasegawa K; Oomori K; Shiratori K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():93-7. PubMed ID: 15453294
    [No Abstract]   [Full Text] [Related]  

  • 27. The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus.
    Kafatos G; Anastassopoulou C; Nardone A; Andrews N; Barbara C; Boot HJ; Butur D; Davidkin I; Gelb D; Griskevicius A; Hesketh L; Icardi G; Jones L; Kra-Oz Z; Miller E; Mossong J; Nemecek V; de Ory F; Sobotová Z; Thierfelder W; Van Damme P; Hatzakis A
    J Viral Hepat; 2007 Apr; 14(4):260-8. PubMed ID: 17381718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Atypical serologic patterns in hepatitis B virus infection].
    Muñoz Criado S; Muñoz Bellido JL; García Rodríguez JA
    Rev Clin Esp; 1997 Jul; 197(7):507-11. PubMed ID: 9411549
    [No Abstract]   [Full Text] [Related]  

  • 29. Routine hepatitis B virus DNA testing in human immunodeficiency virus-infected patients with positive hepatitis B core antibody but negative hepatitis B surface antigen is not justified by current evidence.
    Núñez M
    Hepatology; 2010 Mar; 51(3):1087-8. PubMed ID: 19960553
    [No Abstract]   [Full Text] [Related]  

  • 30. Excess HBcAg in HBc antibody-negative chronic hepatitis B virus carriers.
    Lazizi Y; Dubreuil P; Pillot J
    Hepatology; 1993 Jun; 17(6):966-70. PubMed ID: 8514269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
    Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of 5 kinds of China-made enzyme immunoassay kits for antibody to hepatitis B virus e antigen detection].
    Wang F; Ma JC; Yu T
    Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):396-9. PubMed ID: 20084962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serologic markers of hepatitis B virus. Recent progress].
    Mora Pérez I; Porres Cubero JC; Carreño García V
    Rev Clin Esp; 1984 Apr; 173(1):9-14. PubMed ID: 6330799
    [No Abstract]   [Full Text] [Related]  

  • 34. [Differential diagnosis of Hepatitis A, B, C, D and E. Clinical, biochemical and viral serologic criteria. 3: Serology--hepatitis B].
    Eisenburg J
    Fortschr Med; 1995 Jan; 113(1-2):41-2, 45. PubMed ID: 7883265
    [No Abstract]   [Full Text] [Related]  

  • 35. [Delta hepatitis as a mixed infection].
    Fedorchenko SV; Vovk AD; Vozianova SV
    Vrach Delo; 1990 Mar; (3):5-8. PubMed ID: 2195767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of two chemiluminescent immunoassays of ADVIA Centaur for hepatitis B serology markers.
    Chen D; Kaplan L; Liu Q
    Clin Chim Acta; 2005 May; 355(1-2):41-5. PubMed ID: 15820476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis B: serological strategy and epidemiological aspects].
    Penna R; Rabagliati AM
    G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation and application of a newly developed highly sensitive HBsAg chemiluminescent enzyme immunoassay for chronic hepatitis B patients].
    Shinkai N; Tanaka Y; Matsuura K; Kani S; Naganuma H; Mizokami M
    Rinsho Byori; 2010 Nov; 58(11):1078-84. PubMed ID: 21229705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The clinical characteristics of viral hepatitis B in patients with chronic kidney failure].
    Aripkhodzhaeva FA; Akalaev RN; Nazarov ShN
    Ter Arkh; 1996; 68(11):21-2. PubMed ID: 9045370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.